Axxcess Wealth Administration LLC raised its place in Becton, Dickinson and Firm (NYSE:BDX – Free Report) by 6.0% within the third quarter, based on the corporate in its most up-to-date 13F submitting with the SEC. The fund owned 9,424 shares of the medical devices provider’s inventory after shopping for a further 537 shares through the interval. Axxcess Wealth Administration LLC’s holdings in Becton, Dickinson and Firm had been value $2,272,000 as of its most up-to-date submitting with the SEC.
A number of different hedge funds have additionally lately modified their holdings of the corporate. UniSuper Administration Pty Ltd grew its place in shares of Becton, Dickinson and Firm by 225.9% through the 1st quarter. UniSuper Administration Pty Ltd now owns 7,775 shares of the medical devices provider’s inventory valued at $1,924,000 after buying a further 5,389 shares through the interval. Cetera Funding Advisers elevated its place in Becton, Dickinson and Firm by 380.8% within the first quarter. Cetera Funding Advisers now owns 58,923 shares of the medical devices provider’s inventory value $14,580,000 after shopping for a further 46,668 shares over the last quarter. Canada Pension Plan Funding Board raised its stake in shares of Becton, Dickinson and Firm by 15.6% within the first quarter. Canada Pension Plan Funding Board now owns 280,193 shares of the medical devices provider’s inventory valued at $69,334,000 after shopping for a further 37,851 shares through the interval. M&G Plc lifted its place in shares of Becton, Dickinson and Firm by 0.9% through the 2nd quarter. M&G Plc now owns 709,259 shares of the medical devices provider’s inventory valued at $165,967,000 after shopping for a further 6,052 shares over the last quarter. Lastly, Benson Funding Administration Firm Inc. grew its stake in shares of Becton, Dickinson and Firm by 13.2% through the third quarter. Benson Funding Administration Firm Inc. now owns 22,315 shares of the medical devices provider’s inventory value $5,380,000 after buying a further 2,602 shares through the interval. Institutional traders personal 86.97% of the corporate’s inventory.
Becton, Dickinson and Firm Worth Efficiency
Shares of Becton, Dickinson and Firm inventory opened at $234.73 on Tuesday. The enterprise’s 50-day transferring common worth is $237.04 and its 200-day transferring common worth is $235.10. The agency has a market capitalization of $67.85 billion, a PE ratio of 39.52, a price-to-earnings-growth ratio of 1.73 and a beta of 0.43. Becton, Dickinson and Firm has a 12 month low of $218.75 and a 12 month excessive of $249.89. The corporate has a present ratio of 1.17, a fast ratio of 1.36 and a debt-to-equity ratio of 0.69.
Becton, Dickinson and Firm (NYSE:BDX – Get Free Report) final introduced its quarterly earnings information on Thursday, November seventh. The medical devices provider reported $3.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.77 by $0.04. The corporate had income of $5.44 billion through the quarter, in comparison with analysts’ expectations of $5.38 billion. Becton, Dickinson and Firm had a internet margin of 8.55% and a return on fairness of 14.89%. The agency’s income was up 6.9% on a year-over-year foundation. Throughout the identical quarter within the prior yr, the corporate earned $3.42 EPS. Promote-side analysts forecast that Becton, Dickinson and Firm will submit 14.37 EPS for the present fiscal yr.
Becton, Dickinson and Firm Will increase Dividend
The enterprise additionally lately introduced a quarterly dividend, which might be paid on Tuesday, December thirty first. Stockholders of document on Monday, December ninth might be paid a $1.04 dividend. This represents a $4.16 dividend on an annualized foundation and a dividend yield of 1.77%. The ex-dividend date is Monday, December ninth. It is a optimistic change from Becton, Dickinson and Firm’s earlier quarterly dividend of $0.95. Becton, Dickinson and Firm’s payout ratio is 63.97%.
Analysts Set New Worth Targets
BDX has been the topic of quite a few analysis stories. StockNews.com upgraded shares of Becton, Dickinson and Firm from a “maintain” score to a “purchase” score in a analysis report on Thursday, August eighth. Stifel Nicolaus boosted their goal worth on shares of Becton, Dickinson and Firm from $270.00 to $280.00 and gave the corporate a “purchase” score in a report on Friday, July twenty sixth. Citigroup raised Becton, Dickinson and Firm from a “impartial” score to a “purchase” score and raised their worth goal for the inventory from $255.00 to $275.00 in a report on Tuesday, October 1st. Evercore ISI upped their goal worth on shares of Becton, Dickinson and Firm from $286.00 to $290.00 and gave the inventory an “outperform” score in a report on Tuesday, October 1st. Lastly, Raymond James lowered their worth goal on Becton, Dickinson and Firm from $275.00 to $270.00 and set an “outperform” score on the inventory in a report on Friday, August 2nd. Eight analysts have rated the inventory with a purchase score, Primarily based on information from MarketBeat, Becton, Dickinson and Firm presently has a consensus score of “Purchase” and a consensus goal worth of $283.00.
Examine Out Our Newest Inventory Report on BDX
About Becton, Dickinson and Firm
Becton, Dickinson and Firm develops, manufactures, and sells medical provides, units, laboratory tools, and diagnostic merchandise for healthcare establishments, physicians, life science researchers, medical laboratories, pharmaceutical trade, and most people worldwide. The corporate operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Learn Extra
Obtain Information & Scores for Becton Dickinson and Firm Each day – Enter your electronic mail handle beneath to obtain a concise each day abstract of the most recent information and analysts’ rankings for Becton Dickinson and Firm and associated corporations with MarketBeat.com’s FREE each day electronic mail publication.
